Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endobronchial fibrin glue closure for pulmonary air leakage in spontaneous pneumothorax
jRCTs041240154Not yet recruiting
- Sponsor
- Nagoya University Hospital
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of tachosil in Spontaneous pneumothorax (SP) and air-leak syndrome, sponsored by Nagoya University Hospital. Primary endpoint: Incidence of complications related to fibrin glue injection within 2 weeks. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
tachosil
03
Conditions
Spontaneous pneumothorax (SP)air-leak syndrome
Beyond the preview
Go deeper on jRCTs041240154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240154.